{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:02:12Z","timestamp":1786554132888,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HPF\/2010\/17"],"award-info":[{"award-number":["HPF\/2010\/17"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["TRA\/2007\/5"],"award-info":[{"award-number":["TRA\/2007\/5"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bbi.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T01:50:50Z","timestamp":1570672250000},"page":"153-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy"],"prefix":"10.1016","volume":"83","author":[{"given":"Karen M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Allers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Harkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.10.005_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.brs.2019.05.018","article-title":"The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites","author":"Aarsland","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.bbi.2019.10.005_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2019.10.005_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","article-title":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy","volume":"100","author":"Allen","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2019.10.005_b0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fnins.2018.00386","article-title":"Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression","volume":"12","author":"Allen","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2019.10.005_b0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","article-title":"Role of Kynurenine pathway and its metabolites in mood disorders: a systematic review and meta-analysis of clinical studies","volume":"92","author":"Arnone","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2019.10.005_b0030","series-title":"Hamilton Rating Scale for Depression, ECDEU version used in the Treatment of Depression Collaborative Research Program","author":"Beckham","year":"1985"},{"key":"10.1016\/j.bbi.2019.10.005_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/IJTR.S7052","article-title":"Effects of kynurenine pathway inhibition on NAD metabolism and cell viability in human primary astrocytes and neurons","volume":"4","author":"Braidy","year":"2011","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.bbi.2019.10.005_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.psychres.2011.03.012","article-title":"The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes","volume":"188","author":"Claes","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2019.10.005_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0327(89)90051-7","article-title":"Decreased plasma tryptophan levels in major depression","volume":"16","author":"Cowen","year":"1989","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2019.10.005_b0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fpsyt.2018.00739","article-title":"Mitochondria, microglia, and the immune system-how are they linked in affective disorders?","volume":"9","author":"Culmsee","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jnc.13496","article-title":"Central kynurenine pathway shift with age in women","volume":"136","author":"de Bie","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2019.10.005_b0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2019.10.005_b0070","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/oby.21199","article-title":"The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation","volume":"23","author":"Favennec","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbi.2019.10.005_b0075","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)","author":"First","year":"1996"},{"key":"10.1016\/j.bbi.2019.10.005_b0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0085","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbi.2019.10.005_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","article-title":"The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway","volume":"48","author":"Guloksuz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.10.005_b0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/YCT.0000000000000127","article-title":"The immune system and electroconvulsive therapy for depression","volume":"30","author":"Guloksuz","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.bbi.2019.10.005_b0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-1781(01)00282-7","article-title":"Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression","volume":"103","author":"Hoekstra","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2019.10.005_b0105","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbi.2012.05.010","article-title":"Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation","volume":"26","author":"Hughes","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.10.005_b0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1017\/S0033291716002737","article-title":"Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Kolshus","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2019.10.005_b0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","article-title":"A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers","volume":"48","author":"Lopresti","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/oby.20491","article-title":"Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome","volume":"22","author":"Mangge","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbi.2019.10.005_b0125","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","article-title":"Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Midttun","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.bbi.2019.10.005_b0130","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00216-012-6602-6","article-title":"High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS\/MS","volume":"405","author":"Midttun","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bbi.2019.10.005_b0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbi.2019.10.005_b0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2019.10.005_b0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00702-011-0741-3","article-title":"The role of the kynurenine metabolism in major depression","volume":"119","author":"Myint","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbi.2019.10.005_b0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","article-title":"Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders","volume":"112","author":"O'Farrell","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2019.10.005_b0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: a systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2019.10.005_b0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.12740\/PP\/61584","article-title":"Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy","volume":"51","author":"Olajossy","year":"2017","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.bbi.2019.10.005_b0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.psychres.2005.07.010","article-title":"Changes in plasma amino acids after electroconvulsive therapy of depressed patients","volume":"137","author":"Palmio","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2019.10.005_b0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/pterid-2015-0002","article-title":"In psychiatrically healthy individuals, overweight women but not men have lower tryptophan levels","volume":"26","author":"Raheja","year":"2015","journal-title":"Pteridines"},{"key":"10.1016\/j.bbi.2019.10.005_b0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","volume":"68","author":"Reus","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2019.10.005_b0190","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1017\/S0033291718002556","article-title":"Peroxisome proliferator activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy","volume":"49","author":"Ryan","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2019.10.005_b0195","article-title":"The kynurenine pathway: a finger in every pie","author":"Savitz","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2019.10.005_b0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2019.10.005_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.bbi.2019.10.005_b0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/appi.ajp.2015.15030372","article-title":"Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial","volume":"173","author":"Semkovska","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2019.10.005_b0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2019.10.005_b0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.12092","article-title":"A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study","volume":"173","author":"Theofylaktopoulou","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbi.2019.10.005_b0230","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2019.10.005_b0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2019.10.005_b0240","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2019.10.005_b0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","article-title":"Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review","volume":"11","author":"Yrondi","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.bbi.2019.10.005_b0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0447.2005.00625.x","article-title":"HPA axis normalization, estimated by DEX\/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures","volume":"112","author":"Yuuki","year":"2005","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119303836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119303836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:22:43Z","timestamp":1777576963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119303836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":50,"alternative-id":["S0889159119303836"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.10.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}